Hudan Liu

4.2k citations
53 papers · 2.9k indexed · 1 hit paper · h-index 25
Topics
RNA modifications and cancer (15 papers)RNA Research and Splicing (11 papers)Epigenetics and DNA Methylation (10 papers)

In The Last Decade

Hudan Liu

51 papers receiving 2.9k citations

Hit Papers

Targeting oncogenic Myc as a strategy for cancer treatment20182026202020232018100200300400500

Peers

Hudan Liu
Comparison fields: 5 of 122
  • Molecular Biology 2.2k
  • Cancer Research 872
  • Oncology 491
  • Immunology 243
  • Cell Biology 175
Replace Massimo Zollo with:
Massimo Zollo Italy
Darren N. Saunders Australia
Sergey V. Ivanov United States
Jiyang Yu United States
Mikhail A. Nikiforov United States
Lijun Jia China
Qiaojia Huang China
Fei Lu China
Johan R. Lillehaug Norway
Deirdre A. Nelson United States
Hudan Liu relative to Massimo Zollo Italy Massimo Zollo's profile →
Citations per field
00.5×2.9×
Massimo Zollo · 1×
Citations per year

Countries citing papers authored by Hudan Liu

Since Specialization
Citations

This map shows the geographic impact of Hudan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hudan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hudan Liu more than expected).

Fields of papers citing papers by Hudan Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hudan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hudan Liu. The network helps show where Hudan Liu may publish in the future.

Co-authorship network of co-authors of Hudan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Hudan Liu. A scholar is included among the top collaborators of Hudan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hudan Liu. Hudan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 7
5 6
6 2
7 7
8 10
9 28
10 24
11
Targeting oncogenic Myc as a strategy for cancer treatmentbreakdown →
582
12 30
13 29
14 26
15 22
16 29
17 241
18 30
19 32
20 71

About Hudan Liu

Hudan Liu is a scholar working on Cancer Research, Molecular Biology and Neurology, having authored 53 papers that have together received 2.9k indexed citations. Recurring topics across this work include RNA modifications and cancer (15 papers), RNA Research and Splicing (11 papers) and Epigenetics and DNA Methylation (10 papers). The work is most often cited by research in Cancer Research (872 citations), Molecular Biology (2.2k citations) and Oncology (491 citations). Hudan Liu has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Guoliang Qing, Hui Chen, Megerditch Kiledjian, Rongfu Tu, Yang Dong, Xinfu Jiao, Ming Yue, Jue Jiang, Daibiao Xiao and Yufeng Hu. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026